251 related articles for article (PubMed ID: 26551674)
21. Formulation and Coating of Alginate and Alginate-Hydroxypropylcellulose Pellets Containing Ranolazine.
Segale L; Mannina P; Giovannelli L; Muschert S; Pattarino F
J Pharm Sci; 2016 Nov; 105(11):3351-3358. PubMed ID: 27653554
[TBL] [Abstract][Full Text] [Related]
22. Influence of the aqueous film coating process on the properties and stability of tablets containing a moisture-labile drug.
Ruotsalainen M; Heinämäki J; Taipale K; Yliruusi J
Pharm Dev Technol; 2003; 8(4):443-51. PubMed ID: 14601968
[TBL] [Abstract][Full Text] [Related]
23. Aqueous Polymer Dispersion Coating Used for Osmotic Pump Tablets: Membrane Property Investigation and IVIVC Evaluation.
Cheng L; Gai X; Wen H; Liu D; Tang X; Wang Y; Wang T; Pan W; Yang X
AAPS PharmSciTech; 2018 Jan; 19(1):242-250. PubMed ID: 28695327
[TBL] [Abstract][Full Text] [Related]
24. Development and evaluation of chitosan and chitosan/Kollicoat® Smartseal 30 D film-coated tablets for colon targeting.
Drechsler M; Garbacz G; Thomann R; Schubert R
Eur J Pharm Biopharm; 2014 Nov; 88(3):807-15. PubMed ID: 25301294
[TBL] [Abstract][Full Text] [Related]
25. Formulation and process considerations affecting the stability of solid dosage forms formulated with methacrylate copolymers.
Petereit HU; Weisbrod W
Eur J Pharm Biopharm; 1999 Jan; 47(1):15-25. PubMed ID: 10234523
[TBL] [Abstract][Full Text] [Related]
26. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
27. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
Rujivipat S; Bodmeier R
Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
[TBL] [Abstract][Full Text] [Related]
28. Drug release mechanisms from Kollicoat SR:Eudragit NE coated pellets.
Cuppok Y; Muschert S; Marucci M; Hjaertstam J; Siepmann F; Axelsson A; Siepmann J
Int J Pharm; 2011 May; 409(1-2):30-7. PubMed ID: 21354465
[TBL] [Abstract][Full Text] [Related]
29. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
Kumar RV; Sinha VR
Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
[TBL] [Abstract][Full Text] [Related]
30. Compression of pellets coated with various aqueous polymer dispersions.
Dashevsky A; Kolter K; Bodmeier R
Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
[TBL] [Abstract][Full Text] [Related]
31. Importance of glassy-to-rubbery state transitions in moisture-protective polymer coatings.
Bley O; Siepmann J; Bodmeier R
Eur J Pharm Biopharm; 2009 Sep; 73(1):146-53. PubMed ID: 19446025
[TBL] [Abstract][Full Text] [Related]
32. An Update of Moisture Barrier Coating for Drug Delivery.
Yang Q; Yuan F; Xu L; Yan Q; Yang Y; Wu D; Guo F; Yang G
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31480542
[TBL] [Abstract][Full Text] [Related]
33. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.
Li XN; Guo HX; Heinamaki J
J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615
[TBL] [Abstract][Full Text] [Related]
34. Development of enteric-coated fixed dose combinations of amorphous solid dispersions of ezetimibe and lovastatin: Investigation of formulation and process parameters.
Riekes MK; Dereymaker A; Berben P; Augustijns P; Stulzer HK; Van den Mooter G
Int J Pharm; 2017 Mar; 520(1-2):49-58. PubMed ID: 28153650
[TBL] [Abstract][Full Text] [Related]
35. Solid state properties and drug release behavior of co-amorphous indomethacin-arginine tablets coated with Kollicoat® Protect.
Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
Eur J Pharm Biopharm; 2017 Oct; 119():150-160. PubMed ID: 28602869
[TBL] [Abstract][Full Text] [Related]
36. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
37. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
38. Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble, organic acid.
Crotts G; Sheth A; Twist J; Ghebre-Sellassie I
Eur J Pharm Biopharm; 2001 Jan; 51(1):71-6. PubMed ID: 11154906
[TBL] [Abstract][Full Text] [Related]
39. Influence of fumed silicon dioxide on the stabilization of Eudragit RS/RL 30 D film-coated theophylline pellets.
Kucera SA; Stimpel D; Shah NH; Malick AW; Infeld MH; McGinity JW
Pharm Dev Technol; 2008; 13(3):245-53. PubMed ID: 18484493
[TBL] [Abstract][Full Text] [Related]
40. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
